Skip to content
TrialScanner

NCT00343460

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Phase 3CompletedHRTXLead

Registry record

Lead sponsor
Heron Therapeutics
Conditions
Nausea and Vomiting; Unspecified Adult Solid Tumor, Protocol Specific
Primary completion
Sep 2008Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00343460 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00343460: APF530 or Aloxi (Palonosetron... | TrialScanner